BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29208612)

  • 1. Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women.
    Marchand GB; Carreau AM; Weisnagel SJ; Bergeron J; Labrie F; Lemieux S; Tchernof A
    Am J Physiol Endocrinol Metab; 2018 May; 314(5):E448-E456. PubMed ID: 29208612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study.
    Karelis AD; Pasternyk SM; Messier L; St-Pierre DH; Lavoie JM; Garrel D; Rabasa-Lhoret R
    Appl Physiol Nutr Metab; 2007 Dec; 32(6):1089-96. PubMed ID: 18059582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans.
    Fernández-Real JM; Sanchis D; Ricart W; Casamitjana R; Balada F; Remesar X; Alemany M
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):253-60. PubMed ID: 10396370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional body fat distribution and metabolic profile in postmenopausal women.
    Piché ME; Lapointe A; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
    Metabolism; 2008 Aug; 57(8):1101-7. PubMed ID: 18640388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.
    Brochu M; Starling RD; Tchernof A; Matthews DE; Garcia-Rubi E; Poehlman ET
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2378-84. PubMed ID: 10902782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women.
    Kim JW; Kim DY
    Metab Syndr Relat Disord; 2012 Dec; 10(6):452-7. PubMed ID: 22989086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women?
    Brochu M; Tchernof A; Turner AN; Ades PA; Poehlman ET
    Metabolism; 2003 May; 52(5):599-604. PubMed ID: 12759890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
    Marlatt KL; Redman LM; Beyl RA; Smith SR; Champagne CM; Yi F; Lovejoy JC
    Am J Obstet Gynecol; 2020 Apr; 222(4):365.e1-365.e18. PubMed ID: 31610152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study.
    Tousignant B; Faraj M; Conus F; Garrel D; Brochu M; Rabasa-Lhoret R; Coderre L
    Int J Obes (Lond); 2008 Nov; 32(11):1626-32. PubMed ID: 18838980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women.
    Lapointe A; Tchernof A; Lamarche B; Piché ME; Weisnagel J; Bergeron J; Lemieux S
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):254-60. PubMed ID: 20153614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between circulating free fatty acids, visceral adipose tissue accumulation, and insulin sensitivity in postmenopausal women.
    Lapointe A; Piché ME; Weisnagel SJ; Bergeron J; Lemieux S
    Metabolism; 2009 Feb; 58(2):180-5. PubMed ID: 19154950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
    Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin isoform distribution in women--relationship to female sex steroids and insulin sensitivity.
    Leung KC; Xu A; Craig ME; Martin A; Lam KS; O'Sullivan AJ
    Metabolism; 2009 Feb; 58(2):239-45. PubMed ID: 19154958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
    Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC; D'Agostino RB; Haffner SM; Otvos JD
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action.
    Pereira RI; Casey BA; Swibas TA; Erickson CB; Wolfe P; Van Pelt RE
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4456-62. PubMed ID: 26425886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present?
    Arslanian S; Suprasongsin C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1058-62. PubMed ID: 8772576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.